Relapse and future plans

It’s been a while since I wrote.  I began relapsing during the talquetamab/daratumumab/pomalidomide trial.  I participated for about a year. The drugs worked for a good while – from June, 2021 until May, 2022.

Here are graphs of the free light chains (ratio and free lambda)

I have an appointment on September 20th to discuss the possibility of CAR T-Cell Therapy. Right now, I’m doing bridge therapy.   Cyclophosphamide, carfilzomib, and dexamethasone.  I’ve had this before, but I did relapse while on it. I hope it gets me through!

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.